Sab Biotherapeutics Inc (SABS)

Sab Biotherapeutics Inc (SABS) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
	16.90%23.38	20.00	15.77	12.68	9.73
Research and Development	20.70%16.17	13.40	10.73	8.97	7.00
Operating Income/Loss	16.90%-23.38	-20.00	-15.77	-12.68	-9.73
Nonoperating Income/Loss	21.51%0.89	1.13	-1.09	58.12	-0.38
	19.20%-22.49	-18.87	-16.86	45.45	-10.11
Attributable To Parent	19.20%-22.49	-18.87	-16.86	45.45	-10.11
Available To Common Stockholders, Basic	19.20%-22.49	-18.87	-2.85	5.34	-10.11
Basic Average Shares	48.91%79.75	53.56	9.56	10.66	9.29
Diluted Average Shares	48.91%79.75	53.56	31.04	77.86	9.29
Basic Earnings Per Share	20.00%-0.28	-0.35	-0.51	0.50	-1.09
Diluted Earnings Per Share	20.00%-0.28	-0.35	-0.46	-0.21	-1.09